The PSMA PET radiopharmaceutical 64Cu-SAR-bisPSMA, which previously garnered two FDA fast track designations, more than doubled the detection of PCa lesions in comparison to 68Ga-PSMA-11 in the phase II Co-PSMA trial.
News|Slideshows|August 22, 2026
Radiology Roundup of FDA News: August 16 — August 22
Author(s)Diagnostic Imaging Staff
Catch up on a variety of FDA news in radiology from the past week.
Advertisement
From an emerging radiopharmaceutical for PET imaging of clear cell renal cell carcinoma to updated AI software for detecting breast arterial calcification on mammograms to AI-powered PET software for automated assessment of Alzheimer’s disease and other neurological conditions, here are key FDA news developments in radiology from the past week.
Advertisement
Related to this article
In a recent interview, Carolynn DeBenedectis, MD, discussed the utility of AI-enabled slab reconstruction for interpretation of digital breast tomosynthesis (DBT) and new research showing a 13 percent reduction in reading time.
Catch up on the top radiology content of the past week.
Report One, reportedly the first agentic reporting tool specifically geared to breast imaging, is one of three new products that will be showcased by MagView at the upcoming RSNA conference.
While contrast-enhanced mammography (CEM) offered the highest agreement with histopathology on the extent of malignancy in a new study, researchers found the use of pre-op CEM had no impact on mastectomy or reoperation rates.
Catch up on the top radiology content of the past week.
In a new podcast episode, Manisha Bahl, MD, MPH, FSBI, discusses recently published guidelines on proliferative breast lesions with atypia and lobular carcinoma in situ (LCIS).
In a new podcast episode, Manisha Bahl, MD, MPH, FSBI, reviews key findings from a recent study examining the utility of contrast-enhanced mammography in prevalence and screening rounds.
Advertisement
Advertisement
Trending on Diagnostic Imaging
1
Agfa Radiology to Introduce AI-Powered DR 100s Pro X-Ray Platform at RSNA
2
CMS Reverses Decision and Issues New Outpatient CPT Code for Ultrasound-Based QTscan
3
Breast Ultrasound Study: High Glandular Tissue Component May Double Recurrence Risk for Invasive Breast Cancer
4
Could an Emerging NacBI-RADS System for mpMRI Bolster Assessment of NAC Response?
5